Wallhauser (1933 ( )' Uddstr6mer (1934 Sternberg (1936) Baker and Mann (1939) Longscope (Baker and Mann, 1939) Goldman (1940) Symmers (1944) Jackson and Parker (1947) (Craver, 1957; Hoster et al., 1949) . Involvement of the liver is generally, but not always, cited as occurring in conjunction with involvement of the spleen (Craver, 1957; Wallhauser, 1933; Ziegler, 1911) . Coronini (1928) , Gruber (1930) , and Foulon (1932) distinguish the following types of hepatic involvement by Hodgkin's disease; (1) capsular, (2) nodular or granulomatous lesions localized to the portal triad, (3) diffuse, and (4) encroachment upon or invasion of blood vessels. Simonds (1926) first noted Hodgkin's lesions invading the portal vein. According to some investigators, Hodgkin's disease primarily invades the liver within the portal spaces (Schmorl, 1922; Sternberg, 1936) , while others claim that it extends along the periportal spaces (Fabian, 1911; Ziegler, 1911) or along the major biliary ducts and portal vein (Chevallier and Bernard, 1932; Sternberg, 1936) . In Hodgkin's granuloma one encounters focal circumscribed lesions or yellow streaks along the course of the portal areas (Jackson and Parker, 1947) , and when extensive fibrosis is present the lesions may resemble gummas (Jackson and Parker, 1947) . The hepatic parenchyma surrounding the large lesions may become atrophic (Sherlock, 1955; Symmers, 1944) or may be completely destroyed. In Hodgkin's sarcoma grayish nodules are seen scattered throughout the liver. These lesions are histologically similar to those in the lymph nodes (Jackson and Parker, 1947) . The occurrence of pathological changes unrelated to Hodgkin's disease has been appreciated by others (Abbatucci and Beatty, 1953; Beatty, 1954; Brunner, 1925; Chevallier and Bernard, 1932; Ewing, 1940; Foulon, 1932; Hoster, Zanes, and von Haam, 1949; Loeper and Lebret, 1940; Longcope, 1903; Muller and Boles, 1927; Reed, 1902; Wallhauser, 1933) . Specifically noted have been tuberculosis, amyloidosis, focal necrosis, fatty degeneration, fibrosis, cirrhosis, viral hepatitis, congestion, and adhesions. Simultaneous, invovlement of the liver with Hodgkin's disease and tuberculosis (Loeper and Lebret, 1940; Wallhauser, 1933) , fatty degeneration (Longcope, 1903; Muller and Boles, 1927; Reed, 1902) and fibrosis (Longcope, 1903; Reed, 1902; Tschekulajev, 1951) has also been reported.
Routine laboratory liver function tests have usually been of little help in the diagnosis of lymphomatous involvement of the liver (Sherlock, 1955) . Bromosulphalein retention and alkaline phosphatase levels may be abnormal (Sherlock, 1955) . According to some, however, the serum alkaline phosphatase level is not as helpful in Hodgkin's disease as in detecting involvement of the liver by cancer (Abbatucci and Beatty, 1953; Ariel and Shahon, 1950; Bodansky and Bodansky, 1952; Mendelsohn and Bodansky, 1952; Ross, Iber, and Harvey, 1956) . A similar negative opinion has been expressed with regard to the serum glutamic oxalacetictransaminase (SGOT) level which is, however, invaluable in the diagnosis of hepatitis (Wroblewski and LaDue, 1955) . Of all the laboratory tests currently in general use, liver biopsy is probably most helpful in establishing the presence of Hodgkin's disease of the liver. But it must be recognized that a negative biopsy does not necessarily exclude the presence of hepatic Hodgkin's disease (Gall, 1956; Lichtman, 1953; Pene, 1952; Pene et al., 1955; Robert, Brechot, and Ruynat, 1957; Sherlock, 1955 (Hill, 1955) (Table III) . Gall bladder Four patients succumbed to cerebral or subarachnoid haemorrhage, or both, in each case apparently secondary to severe thrombocytopenia. In contrast, of seven patients in whom gastrointestinal haemorrhage was a major factor contributing to death, only one showed thrombocytopenia, the source of bleeding in the remaining six being attributable to oesophageal varices (one case), Hodgkin's disease of the stomach (two cases), or duodenal ulcer (three cases). Uraemia was a frequent terminal event (14 cases), and membranous glomerulonephritis was encountered in five of these cases. Gastric perforation secondary to Hodgkin's disease was seen in two cases. Generalized Hodgkin's disease, with debility and 'toxaemia' in the absence of any specific additional cause, was considered the cause of death in 26 cases (24%). Only one patient in the present series was considered to have died as a direct consequence of Hodgkin's disease of the liver. Seventeen cases of other neoplastic growths (15.2%) were encountered in the total necropsy series (Table VII) . Total protein, below 6-0 g./100 ml. Serum albumin, below 4.0 g./100 ml. Serum globulin, below 1-0 g./100 ml. or above 3.0 g./l00 ml. Total serum bilirubin, more than 1.5 mg./100 ml. Cephalin flocculation, 3 + or more after 48 hours Thymol turbidity, more than 5.0 units 'In two cases the values were below 100 mg./100 ml. and in two above 300 mg./100 ml. In the latter two cases, obstructive jaundice was present. The differences in incidence of abnormal tests between Groups A and B were not statistically significant. the size of the liver and spleen. Radiological enlargement of the liver was noted in eight cases (7.1 %) in which it was not detected clinically. In like manner, radiological enlargement of the spleen was found in six cases (5 4%) without clinically palpable splenomegaly.
Liver biopsy was performed in three cases (2*8 %). The biopsy findings are compared with the final anatomical diagnosis of the liver involvement at necropsy in Table XVI . No mortality or morbidity resulted from the procedure. (Coronini, 1928; Foulon, 1932; Gruber, 1930; Jackson and Parker, 1947; Simonds, 1926 The frequent occurrence of other liver pathology, particularly passive congestion, fatty metamorphosis, and haemosiderosis, in all cases of Hodgkin's disease with or without direct involvement of the liver by the primary process, is a striking and important finding. Passive congestion occurred less frequently in livers directly involved with Hodgkin's disease (p=0.05), suggesting that it was unrelated to intrahepatic invasion by Hodgkin's disease. No significant difference was found between the several other categories of hepatic abnormality in relation to the presence or absence of direct involvement by Hodgkin's disease. There is no evidence, therefore, to permit any conclusions regarding local factors predisposing the liver to involvement with Hodgkin's disease.
Passive congestion of the liver, which appeared to be a terminal event in a few instances secondary to congestive heart failure or portal hypertension, was not explicable in most instances by such mechanisms.
The presence of fatty metamorphosis of the liver in an unusually high incidence (20.5 %) suggests the operation of nutritional, metabolic or toxic factors, or all three, as well as anoxia (Popper and Schaffner, 1957) . All four of these mechanisms are readily demonstrated or deduced to be present in patients with advanced Hodgkin's disease. The presence of pathological changes in the pancreas in 36.6% of the cases (Hodgkin's disease 23-2 %, other diseases 13-4 %) may have contributed to the development of fatty liver as well (Woldman, Fishman, and Segal, 1959) . All patients with haemosiderosis of the liver (13-4 %) presented with anaemia, with or without haemolysis, and had received numerous blood transfusions during life. They probably represented, therefore, secondary haemosiderosis.
In the present series, hepatic involvement with Hodgkin's disease appeared to be part of the generalized process, as has been previously maintained (Craver, 1957; Hoster et al., 1948) , and in no instance was Hodgkin's disease limited to the liver alone, as reported in a few cases (Goia, 1935; Symmers, 1944) . Extrahepatic biliary pathology due to Hodgkin's disease was more frequent in cases with associated liver involvement (P=0.05), suggesting that the portal areas provide a preferred channel for direct dissemination of the process.
The spleen was involved by Hodgkin's disease in 78-4% of the cases with hepatic Hodgkin's disease. Other pathological changes were encountered in the spleen in 18.9%, and normal spleens were observed in only 2.7 % of patients with liver involvement. This series confirms the conclusion that '...seldom can the liver be involved and the spleen not' (Ziegler, 191 1) .
Occlusion of the portal or hepatic vein by associated thrombosis, direct tumour compression or blood vessel invasion (72 % of this series) must be considered in the differential diagnosis of the onset of ascites, jaundice, or liver enlargement in patients with hepatic involvement with Hodgkin's disease.
The incidence of liver involvement by Hodgkin's disease is somewhat higher (80%) in the necropsy series than reported by others (Table I) , an expected finding in view of the method of selection of the material.
The sex distribution of patients with Hodgkin's disease of the liver did not differ significantly from the cases without liver involvement or from the expected sex distribution in Hodgkin's disease at large (Diamond, 1958c; Gall and Mallory, 1942; U.S. Department of Health, Education and Welfare, 1958; Wallhauser, 1933) . This is in contrast to the report of Abbatucci and Beatty (1953) that males more frequently exhibited hepatic involvement than could be anticipated on the sex distribution of Hodgkin's disease in general. A critical analysis of the data on which their conclusion was based (31 males and 13 females with liver involvement and 29 males and 19 females without liver involvement in a total series of 82 cases) by the corrected x2 test (Yates) (Hill, 1955) reveals no significant difference from the sex distribution of a number of series of cases of generalized Hodgkin's disease (Diamond, 1958b; Gall, 1956; U.S. Dept. of Health, Education and Welfare, 1958; Wallhauser, 1933) . There is no basis, therefore, for assuming a hormonal influence on the frequency of hepatic involvement with Hodgkin's disease. Massive hepatomegaly, with the liver edge below the pelvic brim, was seen in 8-9 % of the necropsy series, an exception to the statement that marked hepatomegaly is uncommon or rare in Hodgkin's disease (Chevallier and Bernard, 1932; Ziegler, 191 1) . In all cases with massive hepatic enlargement, Hodgkin's disease was found in the liver at necropsy. Sixty-eight per cent of our series exhibited lesser degrees of hepatomegaly, however, and within this group only 52% had Hodgkin's disease involving the liver directly. However, in those cases without clinical evidence of hepatomegaly (20.4 %) of the necropsy series), Hodgkin's disease was found in 60.8%. It would appear, therefore, that with the exception of massive hepatomegaly, there is no good correlation between hepatic enlargement and the presence of Hodgkin's disease in the liver. This may be due, in part, to the lack of correlation between clinical hepatomegaly in life and hepatic weight at necropsy, an observation made with respect to other disease as well and considered to be due to differences in blood content of the organ in life and after death (Schiff, 1957) .
Although it is stated that massive hepatomegaly in Hodgkin's disease is almost always associated with massive splenomegaly (Chevallier and Bernard, 1932; Craver, 1957) , no good correlation was noted in the present series between the degree of hepatomegaly and the presence or degree of associated splenomegaly. Indeed, splenomegaly was absent in 30.4 % of the cases with hepatomegaly in this series. As with the liver, there was no good correlation between the clinical estimate of splenomegaly and the size of the spleen at necropsy, or between the size of the spleen and the presence of Hodgkin's disease within the spleen.
Splenomegaly was encountered more frequently in males than females both in the necropsy series (p =001) and in a larger series of 300 cases of Hodgkin's disease with clinical evidence of liver disease. Such an observation has not been previously recorded but its significance is obscure.
It is clear from this series that hepatomegaly can occur early in the course of Hodgkin's disease and is not limited to the terminal stages as claimed by some (Ackerman and del Regato, 1954) . A comparison of the duration of life from the time of diagnosis of Hodgkin's disease with, and without, hepatomegaly reveals no significant difference. The five-and 10-year survival in our series did not differ statistically from a series of 713 cases reported by Diamond (1958b) (Abbatucci and Beatty, 1953; Sherlock, 1955 (Grossowicz, Hochman, Aronovitch, Izak, and Rachmilewitz, 1957) , and radio-tracer scanning of the liver (Friedell, MacIntyre, and Rejali, 1957) and twelve cases of the 300 (37%) were subject to necropsy and critical clinical and pathological study. In the necropsy series, 66% had direct involvement of the liver with Hodgkin's disease, and 34% exhibited other pathology in the liver.
Seventy-nine per cent of the patients with Hodgkin's disease of the liver also had other pathological changes in this organ, and 32A % had biliary tract disease as well.
Diffuse involvement of the liver by Hodgkin's disease was the most common type of intrahepatic distribution (86.5 %), whereas discrete nodular lesions were found in only 10-8 % and the combined diffuse and nodular type was encountered in only 2.7%.
Hodgkin's granuloma was most frequently localized to the portal triads and was not seen invading the blood vessels.
Hodgkin's sarcoma tended to involve the liver in a more diffuse and extensive manner and frequently invaded the blood vessels.
The larger bile ducts were invaded or compressed by Hodgkin's granuloma or sarcoma in 21.8 % of the cases with liver involvement.
In patients free of Hodgkin's disease in the liver itself but with histological evidence of Hodgkin's disease elsewhere, pathological changes of some kind were found in all livers. Some combination of chronic passive congestion, fatty metamorphosis, or haemosiderosis was encountered in 50% of such cases; biliary tree pathology due to Hodgkin's disease in 10-5%; and unrelated biliary tree pathology in 6-2 %. Statistical analysis of the incidence of hepatic changes indicated no significant correlation of these findings with the presence or absence of direct involvement of the liver by Hodgkin's disease.
Despite the almost uniform finding of liver pathology in patients with Hodgkin's disease in this series, only 2.8% of the patients died as a consequence of clinical liver failure, one attributable to Hodgkin's disease directly and two to intercurrent hepatitis.
The five-and 10-year survival rate in this series, selected on the basis of clinical evidence of hepatic disease, did not differ significantly from the survival rate of Hodgkin's disease in general as encountered at Memorial Hospital. The presence or absence of hepatomegaly, the degree of hepatomegaly, splenomegaly, and sex did not significantly influence survival.
At the present time, on the basis of clinical findings and currently available liver function tests, it is impossible to distinguish reliably between liver disease due to Hodgkin's disease itself and that due to associated hepatic changes. Perhaps the only reliable sign of direct involvement of the liver in the Hodgkin's process is the enlargement of the liver below the pelvic brim.
Statistical analysis of the sex distribution of involvement with Hodgkin's disease failed to confirm a previous report of predilection of males to hepatic Hodgkin's disease. By similar statistical criteria, however, splenic involvement with Hodgkin's disease was more frequent, in our series, than the anticipated incidence. The significance of this observation is obscure.
Clinical hepatomegaly was encountered in 79 5 % of the necropsied series of patients with Hodgkin's disease selected on the basis of evidence of liver disease, and it was seen relatively early, in some instances, in the course of the Hodgkin's process.
It is concluded that hepatic involvement by Hodgkin's disease is but one manifestation of a generalized disease process, that it carries no prognostic significance for survival, that it may occur early or late, and that it is frequently associated with one or more abnormalities of liver structure which may be unrelated to Hodgkin's disease. With the single exception of massive hepatomegaly, no clinical sign establishes the presence of the Hodgkin's process within the liver itself, and liver biopsy, the only currently available test capable of the definitive diagnosis of hepatic Hodgkin's disease, is often interdicted by complicating factors.
